冠昊生物 (300238.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务摘要(单季度)(冠昊生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第四季度2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
单季度财务指标:
 单季度每股收益(元) -------1.00-
 单季度销售毛利率(%) 75.0086.0078.0077.0074.0078.0077.0075.00
 单季度销售净利率(%) -18.008.006.0021.00-107.0010.00-336.0017.00
 单季度净资产收益率ROE(%) -2.002.002.004.00-15.002.00-39.003.00
 单季度总资产净利率ROA(%) -3.001.001.004.00-12.001.00-28.002.00
单季度财务摘要:
 单季度营业总收入(元) 95,229,684.0098,134,142.0098,129,960.00112,684,911.0083,300,867.0091,107,071.0079,949,118.00122,927,958.00
 单季度营业总成本(元) 102,477,804.0079,780,644.0091,195,849.0087,034,936.0097,126,897.0088,866,410.0078,575,517.0095,647,843.00
 单季度营业收入(元) 95,229,684.0098,134,142.0098,129,960.00112,684,911.0083,300,867.0091,107,071.0079,949,118.00122,927,958.00
 单季度营业利润(元) -10,365,831.0010,504,356.006,095,094.0027,754,942.00-60,557,571.006,071,085.00-265,142,786.0027,587,290.00
 单季度利润总额(元) -11,893,822.0010,089,401.006,069,013.0027,824,602.00-61,135,133.006,120,379.00-265,212,468.0027,643,600.00
 单季度净利润(元) -17,060,447.007,927,111.006,132,085.0024,073,789.00-89,412,876.008,909,028.00-268,521,375.0021,363,230.00
 单季度归属母公司股东的净利润(元) -10,265,529.0010,527,950.008,628,111.0022,115,266.00-76,252,048.0012,401,233.00-265,765,410.0021,779,567.00
 单季度经营活动产生的现金流量(元) -5,747,744.0024,551,403.0026,839,138.008,507,031.0018,078,797.0015,531,593.0012,682,958.0024,690,383.00
 单季度投资活动产生的现金流量(元) -27,079,955.00-14,216,971.00-4,098,340.00-5,714,849.001,035,061.00-34,825,417.00-3,863,113.00-2,369,821.00
 单季度筹资活动产生的现金流量(元) 3,246,469.00-12,211,673.00-15,369,180.00-2,989,718.00-36,317,721.00-2,642,288.00-27,167,482.00-4,519,755.00
 单季度现金及现金等价物净增加(元) -28,922,953.00-2,930,848.007,892,156.00-245,730.00-17,597,298.00-21,320,900.00-17,790,492.0017,716,277.00

前瞻产业研究院